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Abstract: A library of 23 pure compounds of varying structural and chemical characteristics was
screened for their quorum sensing (QS) inhibition activity using a synthetic fluorescent Escherichia coli
biosensor that incorporates a modified version of lux regulon of Vibrio fischeri. Four such compounds
exhibited QS inhibition activity without compromising bacterial growth, namely, phenazine carboxylic
acid (PCA), 2-heptyl-3-hydroxy-4-quinolone (PQS), 1H-2-methyl-4-quinolone (MOQ) and genipin.
When applied at 50 µM, these compounds reduced the QS response of the biosensor to 33.7% ± 2.6%,
43.1% ± 2.7%, 62.2% ± 6.3% and 43.3% ± 1.2%, respectively. A series of compounds only showed
activity when tested at higher concentrations. This was the case of caffeine, which, when applied
at 1 mM, reduced the QS to 47% ± 4.2%. In turn, capsaicin, caffeic acid phenethyl ester (CAPE),
furanone and polygodial exhibited antibacterial activity when applied at 1mM, and reduced the
bacterial growth by 12.8% ± 10.1%, 24.4% ± 7.0%, 91.4% ± 7.4% and 97.5% ± 3.8%, respectively.
Similarly, we confirmed that trans-cinnamaldehyde and vanillin, when tested at 1 mM, reduced the
QS response to 68.3% ± 4.9% and 27.1% ± 7.4%, respectively, though at the expense of concomitantly
reducing cell growth by 18.6% ± 2.5% and 16% ± 2.2%, respectively. Two QS natural compounds
of Pseudomonas aeruginosa, namely PQS and PCA, and the related, synthetic compounds MOQ,
1H-3-hydroxyl-4-quinolone (HOQ) and 1H-2-methyl-3-hydroxyl-4-quinolone (MHOQ) were used in
molecular docking studies with the binding domain of the QS receptor TraR as a target. We offer here
a general interpretation of structure-function relationships in this class of compounds that underpins
their potential application as alternatives to antibiotics in controlling bacterial virulence.
Keywords: compounds screening; quorum sensing inhibition; antibacterial; molecular docking
1. Introduction
Bacteria communicate with secreted chemical signalling molecules that act as autoinducers in a
phenomenon known as quorum sensing (QS) which allows them to fulfil a variety of functions, including
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bioluminescence, virulence and biofilm formation, among others [1]. In the case of Gram-negative
bacteria, the autoinducer molecules belong mostly to the family of the acyl homoserine lactones
(AHLs), which accumulate to particular threshold concentrations once the population of cells grow to
sufficient [2,3].
AHL synthesis relies on the synthase LuxI family, while AHL reception depends on LuxR-type
transcriptional regulators, which include the nominal LuxR protein from Vibrio fischeri, but also the
related TraR and LasR from Agrobacterium tumefaciens and P. aeruginosa, among others. These act as
transcriptional activators or repressors of the target QS genes [4–7]. The canonical LuxR protein from
V. fischeri comprises two domains. The N-terminal domain is responsible of AHL binding and also can
mediate protein dimerisation [8]. In contrast, the C-terminal domain contains a helix-turn-helix (HTH)
motif, which is thought to make sequence-specific binding to DNA and to drive RNA polymerase
binding to target promoters [9]. Much research has been conducted in recent years on mutant- LuxR-type
proteins [10–16]. Among these, the TraR protein from Agrobacterium tumefaciens has been thoroughly
studied, and its crystal structure has been solved, revealing the presence of the above mentioned two
functional domains. In TraR, the N-terminal domain binds to N-3-oxooctanoyl-L-homoserine lactone
(OOHL), and the C-terminal domain interacts with the DNA binding domain of the tra box [7,17].
TraR is a dimer in the presence of OOHL, and the TraR-OOHL-tra DNA ternary complex can be used
as a prototype for the large family of AHL-induced transcription activators. The LasR protein of
Pseudomonas aeruginosa shares 70% homology with TraR of A. tumefaciens, and the 3D model of the TraR
active site closely resembles the X-ray structure of the LasR active site [18]. The signal binding sites
in both apo-proteins are highly accessible, so TraR constitutes a useful model receptor which allows
predicting the ability of putative QS inhibitors (QSIs) to block QS-based mechanisms in the human
pathogen P. aeruginosa [19,20].
The development of strategies aimed to block or disrupt QS is gaining momentum. These efforts are
directed to inhibit the production of virulence factors at the site of infection by dismantling the collective
power of bacterial pathogens, an approach known as quorum quenching (QQ) or QS inhibition [21,22].
In the last years, QSIs have attracted significant attention from the scientific community and are
considered as potential weapons and new generation antimicrobials in the therapeutic arsenal against
infections caused by drug-resistant bacteria [23–25].
There are three major approaches to target bacterial QS using QSIs: (i) destruction of the signalling
molecule, (ii) inhibition of signal production, and (iii) inhibition of the receptor [26]. To the date,
most of the literature on QQ is centred in the investigation of AHL-degrading enzymes [27] and more
abundantly, in QSIs that targeted to specific QS regulators of diverse species [26]. These QSIs may
structurally resemble the natural ligand or may on the contrary, have an entirely different molecular
structure [28,29]. QSIs include compounds of diverse sources, both natural and synthetic, and include
fungal metabolites, plant substances, antibiotics, and synthetic derivatives of QS autoinducers or
natural antagonists, to name a few [26–29]. Identification of QSIs is commonly performed through the
screening of compound libraries and biosensor-based analysis of the QS response alone or combined
with computer modelling analysis. These methods have allowed expanding the catalogue of available
QSIs, which includes a variety of AHL analogues, brominated furanones, polyphenolic compounds
and polypeptides [23,26,30–32].
Regarding computer modelling, docking-based screening of candidate QSIs is normally carried
out by using a genetic algorithm on a library of 2344 compounds and calculates their binding free
energy, hence identifying those candidates able to interact with target conserved residues in the
binding site of a LuxR-type model receptor [33]. In-silico screening of ligand databases has thus
become an important strategy towards the discovery of novel QSIs. GRID molecular interaction fields
(GRID-MIFs) is accepted as an efficient method in virtual screening of candidate molecules which target
protein binding sites. It is a computational procedure for detecting energetically favourable binding
regions in proteins and small molecule drugs of known 3D structure. The energies are calculated using
the electrostatic, hydrogen-bond, Lennard Jones, and entropic interactions of chemically selective
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probes with the chosen biological target. The program works by defining a three-dimensional grid of
points that contains the chosen substrate binding site. The above mentioned calculations are repeated
for each node in the three-dimensional grid and for each probe being considered. The results of
these calculations are a collection of three-dimensional matrices, one for each probe-target interaction.
A detailed description of the GRID program, the force field parameters, and details of calculations
can be found elsewhere [34,35]. Briefly, a grid is projected inside the protein regions and cavities
of interest. The probes are functional groups that can move stepwise from grid point to grid point.
The calculated interaction energies of the probes are computed to create the MIFs, which represents the
potential interaction of the protein with a particular chemical group. GRID-MIFs is considered as a
high-throughput screening method to virtually analyse protein-ligand interactions [36,37].
In this study, we have screened 23 potential QS inhibition compounds, representing five groups
according to their chemical structures. We found that seven of them were potent, dose-dependent
inhibitors of the V. fisheri LuxR-based system expressed on recombinant E. coli biosensor cells, including
two unprecedented ones. Another five compounds have shown antibacterial activity, while the
remaining eleven compounds were inert at the tested doses. Moreover, we performed in silico
GRID-MIFs-based computational molecular docking on the 3D crystal structure of TraR that allowed us
to propose a hypothesis on the disparate effects observed experimentally for compounds of chemically
related structure. We propose that our biosensor- and docking-based approaches have a high potential
for drug designing purposes.
2. Results
2.1. Screening a Panel of Potential Quorum Sensing Inhibitors
We selected a panel of 23 pure compounds with the potential to act as inhibitors of LuxR-AHL-
mediated QS. These comprised the following groups, namely: Group (1) lactone analogues, Group
(2) aromatic ring structures, Group (3) heterocyclic compounds, Group (4) Pseudomonas spp- relevant
compounds, and Group (5) structurally unrelated compounds. Figure 1 shows the chemical structures
of the cognate AHL molecules of LuxR and TraR regulators, namely N-3-oxohexanoyl-L-homoserine
lactone (3OC6HSL) and OOHL, respectively.
All 23 compounds were tested using the E. coli Top10 pSB1A3-BBaT9002 biosensor, which expresses
a synthetic version of the lux regulon of V. fischeri and produces a fluorescent as a response to external
(3OC6HSL) [38]. The rate of the density-normalised fluorescence of the E. coli biosensor as a function
of the 3OC6HSL concentration displays a Hill behaviour, with a kHill of 7.48 × 10−10 ± 9.03 × 10−11 M.
At 3OC6HSL concentrations higher than 1 × 10−9 M, the fluorescence response is saturated, while the
fluorescence levels are undetectable at a 3OC6HSL concentration of 1 × 10−10 M [38]. We evaluated the
QS inhibitory effect of our panel of compounds by their ability to reduce the fluorescence response of
this E. coli biosensor without compromising cell growth.
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compounds belonging to the classes 1, 2, 3, namely gardenoside (13) (Figure 2a,d,g), caffeine (11) 
(Figure 2b,e,h) and furanone (4) (Figure 2c,f,i) on the fluorescence (Figure 2a–c), growth (Figure 2d–
f) and density-normalized fluorescence (Figure 2g–i) of the E. coli biosensor. A selection of dose-
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Figure 1. Chemical structures of st i ounds. Group (1) lactone nalogues, Group (2) aromatic
ring structures, Group (3) heterocyclic co o nds, Group (4) Pseudomonas spp.-relevant compounds,
and Group (5) structurally unrelated co pounds. In the Figure are also shown the structure of natural
LuxR and TraR ligands, namely 3OC6HSL and OOHL. Other details of the series of compounds are
given in Materials and Methods section.
Screening of the 23 compounds revealed that they could be classified into three main categories
based on their QS inhibition activity, relative to their effects on bacterial growth. The first category refers
to compounds that have not shown QS inhibition nor antibacterial activities (i.e., no apparent effect on
the fluorescent response and growth of the E. coli biosensor). The second includes compounds with the
ability to reduce the QS response of the biosensor without compromising cell growth. While the third
one comprises compounds with the ability to reduce the QS response at the expense of hampering cell
growth. Figure 2 shows representative dose-response curves of compounds belonging to the classes 1, 2,
3, namely gardenoside (13) (Figure 2a,d,g), caffeine (11) (Figure 2b,e,h) and furanone (4) (Figure 2c,f,i) on
the fluorescence (Figure 2a–c), growth (Figure 2d–f) and density-normalized fluorescence (Figure 2g–i)
of the E. coli bio ensor. A selection of dose-r sponse effects of other compounds is available as
Supporting Information, as discussed below.
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The three compounds are chosen as representatives of the following categories: no inhibition
(gardenoside; a,d,g), QS inhibition in the absence of growth reduction (caffeine; b,e,h) and QS
and growth inhibition (furanone; c,f,i). Results from additional experiments on other compounds are
available in Supporting Information. Data shows the mean and standard deviation of a representative
experiment with triplicated treatments.
Next, we calculated the end-point effect of the 23 candidate compounds on the QS-based
response and growth of the biosensor, relative to those of untreated cells. Figure 3 shows end-point,
relative reduction of density-normalised fluorescence and cell density of compounds tested at fixed
concentrations of 5 × 10−5 M (Figure 3a,b) and 1 × 10−3 M (Figure 3c,d). The rationale behind the
chosen concentrations was based on the maximum water solubility of the compounds. Relative
values close to 1.0 indicate none or negligible effect of a given compound on the density-normalised
response and/or growth of the biosensor. In turn, we considered that relative fluorescence values
significantly lower than 1.0 as were a diagnose of inhibition of the QS-based response, proven that
the relative OD600 values stayed close to 1.0. This condition applied to vanillin (5), caffeine (11) and
trans-cinnamaldehyde (6) applied at 1 × 10−3 M (Figure 3a,b); and to phenazine carboxylic acid (PCA,
19), 2-heptyl-3-hydroxy-4-quinolone (PQS, 14), genipin (12) and 1H-2-methyl-4-quinolone (MOQ, 15)
applied at 5 × 10−5 M. In all cases, the relative QS and OD600 data were compared statistically against
itaconic acid, due to its negligible effect on both parameters.
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E. coli biosensor. (a) Effect of compounds 10, 2, 9, 3, 1, 7, 8, 13, 21, 5, 11, 6, 4, 22; applied at 1 × 10−3 M
on the density-normalised fluorescence of treated cells relative to control cells.
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Relative fluorescence was calculated as follows: the mean of the last ten values of density-normalised
fluorescence over time, corresponding to 246–300 min of incubation (see Figure 2) was divided by the
corresponding values of untreated cells. (b) Effect of compounds 10, 2, 9, 3, 1, 7, 8, 13, 21, 5, 11, 6, 4,
22; applied at 1 × 10−3 M on cell density of treated cells relative to control cells. Relative OD600 was
calculated as follows: the mean of the last 10 OD600 values over time, corresponding to 246–300 min
of incubation (see Figure 2) was divided by the corresponding values of untreated cells. (c). Effect
of compounds 21, 17, 16, 23, 19, 14, 12, 15, 18, 20; applied at 5 × 10−5 M on the density-normalised
fluorescence of treated cells relative to control cells. Relative fluorescence was calculated as in (a,d)
Effect of compounds 21, 17, 16, 23, 19, 14, 12, 15, 18, 20; applied at 5 × 10−5 M on cell density of treated
cells relative to control cells. Relative OD600 was calculated as in (b) t-Student statistical comparisons
were made using itaconic acid as a reference treatment (* p < 0.05, ** p < 0.01, *** p < 0.001 and
**** p < 0.0001). Data show the mean and standard deviation of three independent experiments with
triplicated treatments.
Figure 3a shows that the compounds trans-cinnamaldehyde (6) (p < 0.0001), caffeine (10) (p < 0.0001),
and, to a less extent, vanillin (5) (p < 0.001) can significantly reduce the QS-based fluorescence of
the biosensor when applied at 1 × 10−3 M. Importantly, the QS inhibitory effect of caffeine (10)
was not accompanied by any compromise of cell growth (Figure 3b). As for vanillin (5) (p < 0.01)
and trans-cinnamaldehyde (6) (p < 0.01), they slightly reduced cell growth by 16.0% and 18.6%,
respectively (Figure 3b). Furanone (4) (p < 0.0001), and polygodial (21) (p < 0.0001), which abolished
the QS-based fluorescence of the biosensor at the tested concentration, they concomitantly exerted a
dramatic antibacterial effect (cf. Figure 3a,b). Figure 3c shows that compounds PCA (19) (p < 0.01),
PQS (14) (p < 0.001), genipin (12) (p < 0.001) and MOQ (15) (p < 0.0001) significantly reduced the
density-normalized fluorescence of the biosensor when tested at 5× 10−5 M (Figure 3a) and, importantly,
they did not exert a significant effect on bacterial growth (Figure 3b). By contrast, compounds PYO (18)
(p < 0.0001) and PMS (20) (p < 0.0001), showed a strong deleterious effect both on the QS response of
the biosensor and its growth (cf. Figure 3c,d). We carried out a series of experiments to confirm that
inhibition of the density-normalised fluorescence observed with PYO (18) and genipin (12) at sub-lethal
doses was in fact due to interference with the QS response of the biosensor and not due to GFP
fluorescence quenching. To this end, we used a control E. coli strain Top10 pBCA9445-jtk28282::sfGFP,
which constitutively expresses a super folded version of GFP (sfGFP). We compared the effects of both
compounds in the E. coli biosensor and control strains (Figures S2–S8). In our hands, neither of them
at concentrations in the range 1 × 10−8 M to 1 × 10−4 M (Figures S3–S5) acted as quenchers of sfGFP
fluorescence in the control strain E. coli Top10 pBCA9445-jtk28282::sfGFP. We observed a high degree
of experimental variability and not apparent dose-response effects of PYO at sub-lethal concentrations
ranging from 1 × 10−8 to 1 × 10−4 M (Figure S5). The implications of these disparate observations are
further considered in the Discussion section.
2.2. Computation of GRID-MIFs
The three-dimensional molecular crystal structure of TraR receptor was obtained from the protein
data bank (PDB No. 1L3L). Information about the binding region where the natural ligand OOHL
interacts with TraR was described elsewhere [17]. Favorable interaction points at the binding site of
the receptor was studied with GRID-MIFs. To define the GRID maps at TraR binding site, the Autogrid
utility inbuilt in AutoDockTools 1.5.6 software was applied. Three different chemical probes (HD,
HA, DRY) were used, representing the potentially significant functional group at the binding site.
In Figure 4a the GRID-MIFs generated at TarR binding site is shown. Here, the green patch generated
by DRY probe accounts for the favourable hydrophobic interaction ligand and receptor; blue contours
were generated by HD (donor) probe responsible for favourable hydrogen bonds between receptor
and ligand, and red contours were generated by HA (acceptor) probe, which informs about favourable
hydrogen bonds between ligand and receptor amino acid residues. Comparing with the natural
substrate OOHL (Figure 4b) the dry probe matches with the ring and all carbons in the substrate,
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the HD (blue) probe matches the NH group of substrate and HA (red) matches the O functional group
present in the substrate.Pharmaceuticals 2020, 13, x FOR PEER REVIEW 8 of 25 
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2.3. Docking and Interaction of Selected Compounds
We docked six selected compounds, based on their generated GRID-MIFs, over the binding
domain of TraR. We included the cognate OOHL ligand as a reference. This enabled to gain Information
on dock score, hydrogen bond and hydrophobic interactions. We selected ligand conformations using
that of the natural ligand OOHL into the binding site as a reference (Figure 5a). Thus, we fixed docked
ligand binding poses to that of the natural ligand. In other words, superimposition of the docked
ligand on OOHL conformation in TraR’s crystal structure implied that the aromatic ring of the ligand
coincided with the lactone ring of the natural substrate. Table 1 lists the estimated binding energy
values for the docked compounds. Strikingly, PCA (19) and PQS (14) showed a more negative docking
score (i.e., predicted free energy of binding) than that estimated for the cognate ligand OOHL, which
would in principle indicate a stronger affinity of these two compounds towards the binding site of
TraR (Table 1). Figure 5b shows the docking-predicted binding pose of PCA into TraR’s binding pocket.
Two ligand conformations were identified for PQS (14), namely PQS-conf A (Figure 5c) and PQS-conf
B (Figure 5d and Table 1). Both conformations were similar to OOHL binding pose, only differing
in ring flip, which affects hydrogen bond interactions between ligand and receptor (cf. Figure 5a–c).
The estimated docking score for PQS (14)-conf A was more negative than that of OOHL, whereas the
predicted value for PQS-conf B was less negative, indicating a potential stronger affinity of conf B vs
conf A towards the binding site of TraR (Table 1). Docking scores of smaller ligands, namely MOQ,
HOQ and MHOQ were less negative than that of OOHL, predicting poorer affinities for these ligands
towards TraR (Table 1).
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Table 1. Cumulative results for the compounds docked against TraR protein.
Compound HydrogenBo ding Interactions
Dock Score
(Kcal/mol) Hydrophobic Interactions
OOHL 4 (including Trp 57) −7.58 Leu 40, Tyr 53, Gln 58, Trp 85, Phe101,Ala 105, Ile 110.
MOQ (15) 1 (including Trp 57) −6.16 Tyr 53, Val 72, Trp 85, Phe 101, Tyr 102,Ala 105, Met 127
HOQ (16) 0 −5.72 Trp 57, Tyr 61, Asp 70, Val 72, Trp 85,Phe 101, Met 127
MHOQ (17) 1 (including Trp 57) −5.83 Tyr 53, Asp 70, Val 72, Trp 85, Phe 101,Tyr 102, Ala 105, Met 127, Thr 129
PCA (19) 3 (including Trp 57) −8.01 Leu 40, Tyr 53, Tyr 61, Val 72, Trp 85,Phe101, Tyr 102, Ala 105, Met 127
PQS (14) (conf A) 2 −8.04
Leu 40, Tyr 53, Tyr 61, Val 72, Val 73,
Trp 85, Phe 101, Tyr 102, Ala 105,
Met127, Thr 129
PQS (14) (conf B) 1 (including Trp 57) −6.59
Ala 38, Leu 40, Ala 49, Thr 51, Gln 58,
Tyr 61, Phe 62, Val 72, Trp 85, Phe 101,
Met127
We studied in detail the docking-predicted poses of selected candidates to elucidate the mechanisms
of receptor-ligand possible interactions (Table 1). Figure 5 shows interaction maps of the six selected
compounds (Table 1) with TraR’s binding pocket. Clear from Figure 5a are the presence of four
hydrogen bonds established between the cognate substrate OOHL and specific amino acids at the
binding pocket of the receptors The H- bonds are located as follows: (1) between Trp 57 in TraR and
keto group present in the lactone ring, (2) between Tyr 53 in TraR and the 1-keto group of the lactone,
(3) between Asp 70 in TraR and the imino group in OOHL and (4) between Tyr 61 in TraR and the
3-keto group of OOHL (Figure 5a). Apart from these bonds, the cognate ligand also establishes strong
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hydrophobic interactions with nearby residues, as shown in Table 1. Altogether, it seems that both
hydrophobic and hydrogen bond interactions are important for ligand selectivity. Our docking results
confirm previous docking predictions of binding and pose conformations for OOHL in TraR’s binding
site [18]. Figure 5b shows the docking-predicted map for PCA (19)-TraR interaction (19). Importantly,
our predictions show the presence of three hydrogen bonds with TraR’s binding pocket, namely: (1)
between Trp 57 in TraR and the deprotonated N present in the aromatic group of PCA, (2) and (3)
between Thr 129 in TraR, an intermediate water molecule and the carboxylic acid functional group
of PCA (Figure 5b). Again, our docking predicted several hydrophobic interactions between specific
aminoacids of the binding site of TraR and the aromatic and heterocyclic rings of PCA (19) (Table 1).
Figure 5c shows the predicted maps for PQS-confA and the binding site of TraR. In this case, two
hydrogen bonds are predicted to form, namely: (1) between Thr129 and the keto group present in the
aromatic ring of PQS (14), (2) between a hydroxyl group in PQS and a molecule of water (Figure 5c).
In turn the predicted map for PQS-conf B and TraR interaction (Figure 5d shows one hydrogen bond
formed between Trp 57 in TraR and the keto group present in the aromatic ring ofPQS (14). Both
PQS-conf A and -confB are expected to establish strong hydrophobic interactions with the binding
pocket of TraR, as listed in Table 1 and the long carbon chain of PQS in both poses cover most of the
hydrophobic patch generated by GRID (cf. Figures 4 and 5c,d). Panels e, f and g of Figure 5, illustrate
the prediction interaction maps for TraR and MOQ (15), HOQ (16) and MHOQ (17), respectively.
Docking-predicted poses in the binding site of the receptor are very similar (cf. Figure 5e–g); hence,
the predicted interaction sites for the three of them did not very much. However, in the case of both
MOQ (15) and MOQH (17) an hydrogen bond was predicted between Trp 57 in TraR and the keto group
in the aromatic ring of the ligands (cf. Figure 5e,g), while this interaction was not observed in HOQ
(15) (Figure 5f). Strikingly, a relative inhibition of the QS-based response of the E. coli biosensor was
found to be significantly higher for MOQ (15) than that of HOQ (16) and MOQH (17) (Figure S9). This,
in principle would indicate that the specific position of H-bonding between these kind of molecules
and the binding site of TraR would not necessarily explain per se towards LuxR-based proteins.
3. Discussion
QSIs are gaining momentum as potent alternatives to the use of classical antibiotics in the context
of rising resistance spread and with enormous potential in many fields, from food science to agriculture
and medicine [39,40]. QSIs are structurally diverse molecules that can be synthesised or extracted
from natural sources. Here, we screened a total of 23 chemically diverse compounds with potential
QS inhibition activity to identify their impact on LuxR-regulated QS models. To this end, we used
a well-established E. coli Top10 biosensor assay and in silico modelling to recreate the structural
interactions between the ligand candidates and the LuxR-like receptor.
The candidate compounds were classified into five broad groups according to with their chemical
structure (Table 1). Group 1 comprised the alkyl-substituted lactones (Table 1): γ-valerolactone (1),
L-homoserine lactone (2), α-methyl-γ-butyrolactone (3), and furanone 4. In this group, only furanone
(4) showed a significant inhibition (≥37.5%) of the fluorescent- QS-based response of the biosensor at
concentrations ≥ 5 × 10−6 M 37.5% (Figure 3a and Figure S10). At 1 × 10−3 M, furanone completely
abolished the QS-based response of the biosensor, albeit a dramatic, deleterious effect on cell growth
(Figure 3b and Figure S10).
γ-Butyrolactones were the first class of small signalling molecules identified from Gram-positive
species Streptomyces griseus. They were found to induce streptomycin production and sporulation [41].
Even though the chemical structure of γ-butyrolactones is rather similar to that of AHLs, except for
the carbon side-chain, it is known that the receptors of γ-butyrolactone do not bind to AHL receptors
and that AHL do not bind to γ-butyrolactone receptors. Also, both receptors have low structural
similarity [41]. The functions of the signalling molecules also differ as AHLs i.a. are known to regulate
QS in Gram-negative bacteria, while γ-butyrolactones mainly regulate the production of antibiotics
and differentiation.
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From our results, we found that neither α-methyl-γ-butyrolactone, γ-valerolactone nor
L-homo-serine lactone showed any QS inhibition activity. These results are consistent with the
notion that the carbon side chain is important for binding to the LuxR receptor. Also, it is not
unexpected that γ-valerolactone did not show activity, as the methyl substituent is in a different
position of the lactone ring than that in 3-oxohexanoylhomoserine. As suggested in previous studies,
our results support the proposal that the LuxR receptor does not recognise α-methyl-γ-butyrolactone
nor other related lactones (e.g., γ-valerolactone).
Halogenated furanones which resemble AHLs structurally were first discovered in the marine
red alga Delisea pulchra and proved to preventing swarming motility with the opportunistic human
pathogen Proteus mirabilis and S. liquefaciens without affect growth rate [42,43]. These compounds were
the first QSIs found to occur in nature. After that, Manefield et al. further obtained proof-of-principle
of the QS inhibition activity of the same type of halogenated furanones by specifically interfering with
AHL-mediated gene expression at the level of the LuxR protein [44]. Furthermore, Ren et al. found
that (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone is a non-specific intercellular signal
antagonist [45]. Later, Defoirdt et al. proved that this furanone disrupts quorum sensing-regulated
gene expression in Vibrio harveyi by decreasing the DNA-binding activity of the transcriptional regulator
protein LuxR [46]. Besides halogenated furanones with side alkyl chains that have QS inhibition
activity, some synthetic halogenated furanones lacking alkyl chain also have anti-biofilm formation
activity through interference with QS, and have been found to protect surfaces from being colonised by
S. epidermidis [47]. Compound (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone included in
our library, a synthetic derivate of natural furanone has been reported as a potent antagonist of bacterial
QS that not only can increase bacterial susceptibility to tobramycin and SDS when it is applied for
action with P. aeruginosa biofilms but also can inhibit virulence factor expression because of targeting
QS systems [48]. Several previous studies have shown that halogenated furanones can interact with
the LuxR protein and induce conformational changes due to rapid proteolytic degradation of the
furanone-LuxR complex, which in turn destabilises the AHL-dependent transcriptional activator [49].
However, independent studies confirmed that halogenated furanones without alkyl chains were
strongly toxic to the planktonic cell. While furanones with long alkyl chains were shown not to reduce
the biofilm formation [50,51]. The present study confirmed that furanone without alkyl chains has high
toxicity against the E. coli Top10 pSB1A3-BBaT9002 strain, as it reduced 50% the bacterial growth when
dosed at 5 × 10−5 M. In fact, at 1 × 10−3 M, indeed, furanone can kill all bacteria, diagnostic that the lack
of alkyl chain is at play in the induced toxicity. It has been suggested that the increase of water solubility
may explain this effect [51]. Interestingly, when dosed at 5 × 10−6 M, the results showed that furanone
could reduce the fluorescence production at no detrimental expense of the bacterial growth (Figure 2c).
A possible explanation to these phenomena might be that some compounds when applied at sub-lethal
concentrations will not kill bacterial but delay the QS activity because bacteria become weaker than
at the normal condition. This phenomenon gave us the illusion that those compounds were QSIs,
but when we increased the dose, we noticed that they had an antibacterial activity. The observed
antimicrobial effect at furanone concentrations ≥ 5 × 10−6 M (Figure S10) prompted us to search QSIs
with lower associated toxicity. Closer attention should be paid to this phenomenon to discriminate
between potential QSIs more carefully.
Group 2 candidates included compounds with at least one aromatic ring. Vanillin (5), proposed
as a less toxic alternative to brominated furanones, revealed a relative reduction of the biosensor’s
fluorescent response of 27.1 % when applied at 1 × 10−3 M (Figure 3a and Figure S7), an effect that was
accompanied by a discrete, 16.0% reduction of cell growth (Figure 3b and Figure S7). Belonging to the
same group, the well-reported QSI, trans-cinnamaldehyde (6) revealed a potent capacity to reduce
the QS-based response of the biosensor to up to 68.3% (Figure 3a and Figure S7) when applied at
1 × 10−3 M, with a slight reduction of cell growth (18.6%; Figure 3b and Figure S7). Surprisingly, related
compounds caffeic acid (7) and trans-anethole (8) were apparently innocuous to the E. coli biosensor
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even at concentrations of 1 × 10−3 M (Figure 3a,b) while capsaicin (9) and CAPE (10) inhibited cell
growth by 12.8 and 24.4%, respectively (Figure 3b).
Vanillin (5) is a well-known food flavouring agent and is a major constituent of vanilla pods.
Its QS inhibition activity has recently been demonstrated in Aeromonas hydrophila, Agrobacterium
tumifaciens NTL-4, Chromobacterium violaceum CV026 when applied at 250 µg/mL (1.64 mM), where it
showed significant inhibition in short-chain AHLs (C4-HSL (69%) and 3OC8-HSL (59.8%)), followed
by C6-HSL(32%), and C8-HSL (28%), but lower inhibition in long-chain AHLs (C14-HSL (13.5%)
and C10-HSL (12%)). It also reduces the biofilm formation on the reverse osmosis membrane of A
hydrophila [52]. Our own experiments confirmed that vanillin at 1 × 10−3 M can inhibit the QS activity
with 3OC6HSL 27.1%. It has been speculated that the possible mechanism whereby vanillin inhibits
QS activity is that it interferes with the binding of the short-chain AHLs to their cognate receptor [52].
Our study offers experimental evidence that vanillin may also interfere with binding of 3OC6HSL to
its cognate LuxR receptor.
trans-Cinnamaldehyde (6) is a component of cinnamon and cassia essential oils, and it is commonly
present in food as a flavouring agent and fungicide. In a previous study, it was shown that 200 µM
cinnamaldehyde can reduce by 70% the fluorescence intensity due to the expression of GFP, induced by
3-oxo-C6-HSL in a bioreporter E. coli ATCC 33,456 pJBA89, and also effective at inhibiting AI-2 mediated
QS [53]. Furthermore, Brackman et al. proved trans-cinnamaldehyde at concentrations < 1 mM shifts the
SDS-PAGE mobility of LuxR-DNA. They concluded that trans-cinnamaldehyde and cinnamaldehyde
derivatives interfere with AI-2 based QS in various Vibrio spp. by decreasing the DNA-binding ability
of LuxR [54]. Recent molecular docking analysis studies suggested that trans-cinnamaldehyde interacts
with LasI and EsaI substrate binding sites thus inducing the QS inhibition activity [55]. Our own studies
also confirm that trans-cinnamaldehyde inhibits the LuxR-mediated GFP production in the E. coli Top
10 biosensor by 68.3% at 1 × 10−3 M concentration. This strain does not express the LuxI gene, thus
it cannot produce LuxI synthase of 3-oxo-C6-HSLs but can constitutively overexpress LuxR protein.
In our related study, we have shown that trans-cinnamaldehyde not only inhibits the expression of
GFP, but it also retards its kinetics [38]. We suggest that there are maybe two mechanisms at play for
QS inhibition involving LuxR. Firstly, the three-carbon aliphatic side chain of trans-cinnamaldehyde
could interfere with the binding of 3OC6HSL to LuxR receptor; secondly, it can also decrease the
DNA-binding ability of LuxR dimers, as previously suggested.
trans-Cinnamaldehyde (6)-related compounds, namely caffeic acid (7) and trans-anethole (8), were
also tested on their QS inhibition activity. The results showed that neither of them had QS inhibition
activity nor antibacterial effect at the tested concentration of 1 × 10−3 M. Caffeic acid is a phenolic acid
that has various documented beneficial biological properties. Besides being a powerful antioxidant, it
also has anticancer, anti-inflammatory and antiviral activities [56]. trans-Anethole, in turn, is also a
natural component of anise seeds and fruits and it is used as a flavouring ingredient. Until now, its
antibacterial and QS inhibitory activities have not been tested.
Comparing the chemical structures of caffeic acid and trans-anethole with that of
trans-cinnamaldehyde, we can clearly see that neither the catechol phenolic nor the aromatic ester
groups of caffeic acid and trans-anethole, respectively, have any effect on increasing the binding affinity
with the LuxR protein. These results may reflect the importance of the unsubstituted aromatic ring in
trans-cinnamaldehyde to make π-π interactions with the receptor residues at the binding site of LuxR.
In this regard, the phenolic residues of caffeic acid can act as the H-bond donors, but not acceptors,
at the hydrogen bond acceptor binding domain of the binding pocket of LuxR, hence, decreasing its
overall binding efficiency. Similarly, in trans-anethole, the presence of the methyl ester substituent
at the aromatic ring may be is enough to prevent its efficient binding with the binding site of LuxR.
However, vanillin, with one phenolic, one methyl ester and an aldehyde substituent at the aromatic
ring, does show QS inhibition activity as discussed above. Therefore, our study is consistent with the
idea that the role of the presence of H-bond acceptor groups along with the the π-π interactions of the
aromatic ring, is what determines the overall affinity of compounds to bind with LuxR receptor.
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Capsaicin (9), structurally related to vanillin (5), is a natural alkaloid extracted from fruit of
Capsicum family and it is responsible for the pungency of chili peppers. Its structure has an aromatic
ring and a long hydrophobic aliphatic chain with a polar amide group. Most studies with capsaicin
have addressed its pharmacology and clinical applications [57]. Only a few studies have focused on
the inhibition activity of the growth of the gastric pathogen Helicobacter pylori [58,59]. One such study
found that capsaicin did not inhibit the growth of a human fecal commensal E. coli strain [58]. So far,
the QS inhibitory activity of capsaicin has not been documented. Our results show that even at the
concentration of 1 × 10−3 M, capsaicin did not significantly reduce the QS activity of the E. coli Top10
pSB1A3-BBaT9002 biosensor, and it decreased the bacterial growth only by 12.8% (p < 0.05). If we
compare the structures of capsaicin with that of vanillin, we can observe that they share identical
substitution positions in their aromatic ring, except that vanillin has not the long aliphatic chain, but
only a strong aldehyde H-bond acceptor group. Our results indicate that the increase in the length of the
aliphatic chain does not lead to an increase in binding affinity. CAPE (10) is the main active component
of propolis extract. Its chemical structure is described as the ester of caffeic acid and phenetyl alcohol;
hence, it is a catechol ring with an ester chain bearing another aromatic ring. CAPE has known
bioactivities such as antimicrobial, anti-inflammatory and cytotoxic activities. About the antimicrobial
activity of CAPE, it has been reported that can inhibit the 60% E. coli growth when the concentration is
over 60.6 µM. This has been explained as the result of the synthesis of reactive oxygen species that
damage the outer membrane of the bacteria-induced by CAPE [60,61]. Our experiments contrast with
this study, as we found that CAPE only inhibits the growth of the E. coli Top10 pSB1A3-BBaT9002
strain by 24.4% when applied at 1 × 10−3 M. As a possible explanation for the observed discrepancies
between the results of our study and the previous ones may stem in the distinct protocols of the assays
to quantify the bacterial growth rate. Overall, no QS inhibition activity was shown on the surviving
bacteria after treatment with CAPE.
Group 3, comprised by heterocyclic compounds, revealed candidates with important QSI capacity,
namely caffeine (11) and genipin (12), which have been shown to reduce the QS-based response of the
biosensor by 47% and by 43.3% when applied at 1x10−3 M and 5x10−5 M, respectively (Figure 3a,c,
Figures S7 and S8) and with negligible effects on cell growth (Figure 3b–d, Figures S7 and S8). Belonging
to the same group, gardenoside (13) did not show any apparent effect on the E. coli biosensor at the
doses tested (Figure 3a,b).
Caffeine (11) is yet another alkaloid which occurs in coffee cherry and tea. Documented uses of
caffeine include as a pesticide to kill certain larvae, insects and beetles. Some studies have shown
that caffeine, applied at 2.5 mg/mL (≈12.8 mM), can retard the growth of E. coli, Enterobacter aerogenes,
Proteus vulgaris, and P. aeruginosa within a short time. The first time caffeine was tested as QS inhibition
compound against C. violaceum CV026 and P. aeruginosa PA01 strains, it was found that when applied
at 0.3–1.0 mg/mL (≈1.5–5.0 mM), it inhibits violacein production in C violaceum CV026, and short chain
AHLs production and swarming motility in P. aeruginosa PA01 [62]. Our experiments also proved that
caffeine, applied at 1 × 10−3 M to the E. coli Top10 pSB1A3-BBaT9002 biosensor strain, it can inhibit
47% GFP production without affecting bacterial growth. Our results, along with previous studies [62],
suggest that caffeine has a broad spectrum of QS inhibition activities in different bacterial species;
interestingly, all share in common to contain the AHL-regulated QS system. As earlier reported by
Norizan et al. Caffeine did not degrade C6-HSL [62], so we hypothesise here that it can be a competitor
that binds with AHL receptors because the keto groups from the aromatic ring can also form strong
hydrogen bonds with type I QS LuxI/LuxR receptors.
Also in Group 3, genipin (12) is an iridoid compound isolated from Gardenia jasminodies Ellis
fruits. It is the aglycone derivative of geniposide. It was initially identified as a protein cross-linking
agent but can also inhibit the production of nitric oxide by downregulating the activity of nuclear
factor-κB (NF-κB) [63]. It is also a cell-permeable inhibitor with anti-inflammatory and anti-angiogenic
activity mediated by the induction of apoptosis in hepatoma and hepatocarcinoma cell lines [64].
A number of studies have also shown that genipin cross-links chitosan nano- and microparticles,
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thus allowing them to be used for QS inhibition and the delivery of antimicrobial drugs [65,66].
We found, for the first time, that genipin on its own can inhibit GFP production in the E. coli Top10
pSB1A3-BBaT9002 biosensor, without exhibiting significant toxicity, more effectively than a diverse
spectrum of alternative compounds. Knowing that genipin possesses inherent fluorogenic properties,
we wondered whether the observed effect on the fluorescent response of our biosensor could be due
to an artefact associated with the direct fluorescence quenching [67]. We performed a series of extra
experiments where we tested genipin on the control E. coli strain Top10 pBCA9445-jtk28282::sfGFP
strain (Supporting Information). We found that genipin concentrations ranging from 9.95 × 10−10 to
1.19 × 10−4 M did not exert significant fluorescence quenching on the control strain (Figures S2 and
S3). Nevertheless, the fact that the fluorescence over growth profiles of both bacterial strains widely
differ (Figure S1) make these comparisons a difficult task. Moreover, both strains express different
GFP species (namely GFPmut3b and sfGFP in the biosensor and control strain, respectively) and their
expression vectors widely diverge (see Supporting Information) [68,69]. Future efforts should be
focused on validating the effects of genipin by using a control E. coli Top10 strain expressing GFPmut3b
constitutively from a modified version of the pSB1A3-BbaT9002 plasmid. On our hands, genipin and
related compounds are promising candidates for the development of novel therapeutic approaches
based on the inhibition of QS in bacteria. Our data showed a significant difference between the QS
inhibition activities of genipin and the closely related glycosylated iridoid compound, gardenoside.
These two iridoids share similar structures, differing only with respect to the glycosylation in the
hydroxyl group of C1, and in the hydroxyl group at position C8 of the heterocyclic structure, in
gardenoside. This result may have a biological significance in host-pathogen interactions via inhibition
of QS, as glucose oxidase (GOD) is synthesised by many plants, fungi and bacteria. This hypothesis
would need further experimental validation.
Quinolone- and phenazine- like compounds belonging to Group 4 (Table 1) are reported to play
important roles in QS-regulated phenotypes of Pseudomonas spp [70]. These comprise the alkylquinolone
PQS (14) signal of P. aeruginosa and three structurally-related synthetic quinolones, namely MOQ
(15), HOQ (16) and MHOQ (17) (Table 1); bearing a bicyclic core structure with different substituents.
Among these three structurally-related synthetic compounds, only MOQ demonstrated significant
relative QS inhibition activity of 62.2%. The rest of tested compounds, namely HOQ and MHOQ,
did not have any detectable activity, neither QS inhibition nor antibacterial (Figure 3c,d and Figure
S9). Also, compound PQS comprised not only one six-carbon ring but also a long carbon chain at the
six-member heterocyclic ring, which showed an important QSI activity, by inhibiting the QS-based
response of the biosensor by 43.1%, with a negligible effect on cell growth (Figure 3c,d and Figure S8).
Compounds PYO (18), PCA (19) and PMS (20) are similarly with three rings, but only PYO and PMS
have high GFP inhibition and high toxicity, compound PCA also has QQ activity, inhibiting GFP
production by 33.7%, but no toxicity (Figure 3c,d).
Group 4, comprised heterocyclic compounds, some of which can be produced naturally, such as
the Pseudomonas spp. metabolites (PQS, PCA, PYO), while the rest are synthetic [70]. It is well known
that phenazines have antimicrobial activity [71]. Moreover, some of these compounds are known to act
as signalling molecules that regulate the QS systems in P. aeruginosa as discussed in detail below.
Compound PQS has been found as a QS signal that participates in the P. aeruginosa QS
network and acts as a link between las and rhl quorum sensing, which either directly or indirectly,
mediates the expression of 182 genes in P. aeruginosa [72,73]. Besides the intraspecific signalling
role of PQS in P. aeruginosa involving interactions with its cognate LasR-like PqsR receptor and
non-cognate-LuxR-like-RhlI, there is no evidence to the date on PQS interference with other LuxR-based
QS regulation circuitries. Despite the fact that there is currently no crystal structure available for RhlI,
it is known that it shows significant sequence divergence from TraR, our prototype for docking studies.
Thus, it is unknown how PQS binds to RhlI in P. aeruginosa. A recent paper from Mukherjee et al.
explored ligand-receptor binding of PqsR with C4HSL, by generating a homology model based on the
E. coli SdiA structure, which is a LuxR-like closest homolog of PqsR [74]. In SdiA and other LuxR-type
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proteins, the highly conserved amino acids Trp68 and Asp81 interact with the amide group-oxygen
and the amide group-nitrogen, respectively, of the cognate C4HSL. Other conserved residues, such as
Tyr72 and Trp96, are required for hydrophobic and van der Waals interactions with the ligands [74].
These interactions seem to correlate with our docking predictions of OOHL establishing H-bonding
with Trp57 and hydrophobic interactions with Tyr53 and Trp85 in the binding site of TraR (Figure 5a
and Table 1). A similar scheme of PQS predicted H-bonding and hydrophobic interactions with Trp57
and Tyr61 (Figure 5c,d and Table 1) would in principle serve as a rationale for a strong affinity of
PQS to LuxR homologs and the observed quorum quenching effect on the biosensor’s LuxR-regulated
response (Figure 3c and Figure S8).
Phenazines are a well-known family of pigments that are secreted from P. aeruginosa. Among
phenazines, PYO is widely known due to its cytotoxic and redox activities [75]. Importantly, PYO
is a terminal signalling factor in the QS network of P. aeruginosa [76]. PYO is also an intercellular
signal that triggers specific responses in enteric E. coli and Salmonella enterica, via the SoxR regulon.
Whether this kind of signal transduction is also involved in our E. coli biosensor in the presence of
PYO is a question that we cannot elucidate at present [77]. Also, it is well known that PYO interacts
with molecular oxygen to form ROS species that change the redox balance of the cells and that GFP
fluorescence can be affected by the presence of ROS species [78,79]. To shed some light on extra effects
of PYO on fluorescence quenching and/or the metabolism of E. coli Top 10 cells, we decided to perform
extra experiments applying increasing PYO concentrations on both the E. coli Top10 pSB1A3-T9002
(Figure S4) biosensor and the luxR-deficient E. coli Top10 pBCA9445-jtk28282::sfGFP (Figures S5 and
S6). Strikingly, we found a lack of dose-response effect of PYO on the fluorescence of both strains
(Figures S4–S6), together with strong variability among experiments (cf. Figures S5 and S6). These
disparate results could arise from some of the transductory and/or redox activity of PYO on our E. coli
Top10 cells and need further investigation.
PCA (19) is yet another redox-active phenazine pigment that is produced from P. aeruginosa [80].
PCA is known to be a broad-spectrum activity compound that inhibits the growth of several plant
pathogenic species (e.g., Corynebacterium fascians, Agrobacterium tumefaciens, Erwinia aroideae, Diplodia
zeae) [81,82]. Further studies have found that PCA is precursor for more complex phenazine metabolites,
such as 1-hydroxyphenazine, phenazine-1-carboxamide and PYO [76]. Yun Wang et al. found that
PCA may shift the redox equilibrium between Fe(III) and Fe(II) in P. aeruginosa [83]. Even though
PCA and PYO, both are redox-active phenazines, in our study, we found that, at 5 × 10−5 M, PYO has
strong toxicity to E. coli Top 10 pSB1A3-BBaT9002 strain, while PCA only inhibits the fluorescence
intensity but has no effect on bacterial growth. The different effect of PYO and PCA can be attributed
to the fact that PCA may help the E. coli alleviate Fe(III) limitation by reducing it to ferrous iron [Fe(II)],
thus promoting the bacterial growth [83], thus allowing to observe the QS inhibition activity. We will
discuss further this aspect in the context of the in silico molecular docking results below.
PMS is a simple phenazonium salt and an electron acceptor and carrier in biochemical
oxidation/reduction studies [84,85]. It is also a O2− generating agent that can increase intracellular
H2O2 levels and lead to the formation of free radicals that can affect bacterial growth [85]. This explains
why in our experiments PMS shows strong toxic effect against E. coli Top 10 pSB1A3-BBaT9002 strain.
As explained above, this strain is lacking the SoxR regulon to confer resistance against redox stress.
Previous studies have proved that phenazines are antibiotic compounds that can inhibit microbial
growth because of the redox-active effect. From our own studies, it can be argued that when
phenazines (namely, PCA, PYO, PMS) are applied at the same concentration of 5 × 10−5 M, only
PYO and PMS are toxic to the E. coli Top10 pSB1A3-BBaT9002 strain, as we mentioned above.
Interestingly, PCA, does not inhibit bacterial growth but has QS inhibition activity. Several studies
have also noticed this phenomenon. Morales et al. found that lower concentrations of PCA, PYO
and PMS inhibited the fungal yeast-to-filament transition and affected the development of C. albicans
wrinkled colony biofilms but allowed growth. However, those phenazines have anti-candida activity
when the concentration is higher than 500 µM, which means that those compounds have different
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biological effects at different concentrations [86]. Furthermore, Skindersoe et al. used sub-inhibitory
concentrations of antibiotics in P. aeruginosa and found that lower doses of antibiotics could modulate
gene expression, so that they interfere with QS signalling [87]. To the best of our knowledge, this dual
concentration-dependent activity of phenazines had not been reported before to operate in a mutant
E. coli Top10 pSB1A3-BBaT9002 strain. However, recently, it has been hypothesised that it is a general
mechanism of action of many compounds [88].
For the identification of functional group and their arrangement in the binding site required for
binding ligand, GRID map was generated by using three different chemical probes i.e., H bond donor
(HD), H bond acceptor (HA) and DRY probe. Grid-MIFs generated for TraR indicated (Figure 4) that
acceptor interaction points and hydrophobic patches are dominant in comparison to donor interactions
points at the binding. Comparing the functional group present in ligands with the GRID-MIFs (Figure 4)
it is clear that because of big hydrophobic patch in the center of cavity, hydrophobic interaction from
carbon either from aromatic ring or long chain carbon make very favorable interaction. Apart this one
donor group at one side of aromatic ring makes favorable interaction with the Trp 57. Hydrogen bond
interaction with Trp 57 is identified as important interaction in receptor substrate interaction. Apart
from HOQ we found this interaction in all other five ligands. Whereas at the other side of ring one
donor or one acceptor would also make favorable interaction with the Thr129 or water.
Consequently, we identified that in the same ringside two functional groups e.g. an OH group
just next to the O (acceptor group), do not make a favourable interacting group. This can be observed
in the docking score results for HOQ and MHOQ both with lower scores than MOQ. This might
explain that in vitro HOQ and MHOQ, did not exhibit QS inhibition activity, while MOQ, that lacks
the 3-hydroxyl group did exhibit QS inhibition activity experimentally. PQS showed better score,
i.e., PQS-conf A (−8.04) and PQS-conf B (−6.59), in comparison to HOQ and MHOQ because of the
long alkyl chain and an overall more favourable hydrophobic interaction (Table 1). In the PQS-conf
A (−8.04), the H-bond between the Trp 57 and ligand is missing in this conformation, but because of
PQS has a longer alkyl chain than OOHL, a H-bond with Thr 129 and putative H-bond with water,
PQS-conf A has a better score than the other compounds. Whereas in PQS-conf B (−6.59) the H-bond
is present between ligand O and Trp 57, but because of the OH just next to O is not a favourable
interaction (according to GRID-MIFs), hence its lower score. This analysis clearly indicates that OH
next to O is not a favourable functional group for interaction in ligand PQS, which affects the pose and
docking score. Moreover, because of the H-bond interactions and more hydrophobic interactions in
comparison to natural ligand OOHL, this compound is better over other ligands. Along with PQS,
PCA has also shown a high dock score compared to other ligands. We argue that this is the result of the
combined effect of the three aromatic rings making more hydrophobic interaction, the deprotonated N
present in the aromatic group involved in H-bond interaction with Trp57, and the carboxylate function
group involved in H-bond interaction with Thr129 and also probably with water. These favourable
interactions might explain the high QS inhibition activity observed for PQS and PCA.
Finally, Group 5 contained a more diverse collection of organic molecules with complex structures.
Experimentally, with the exception of compounds itaconic acid at 1 × 10−3 M and berberine at 5 × 10−5
M, none of these compounds showed QS inhibition activity. However, we found that polygodial
exhibited strong bacterial growth inhibition. Polygodial is a bicyclic sesquiterpene dialdehyde, isolated
from different traditional medicinal plants such as Polygonum hydropiper and P. punctatum [89]. Kubo
et al. showed that polygodial has the antibacterial activity against various bacteria, not only as a
surfactant to form the pyrrole with primary amine groups at the plasma membrane, thereby disturbing
the balance of the membranes, but also may react with various intracellular components when it enters
into the cells after the membrane damaged [89]. We also proved that polygodial has high antibacterial
activity that suppressed almost completely the growth of E. coli Top10 pSB1A3-BBaT9002 strain when
dosed at 1 × 10−3 M.
Berberine is an isoquinoline-type alkaloid isolated from Coptidis rhizomaand (“huang lian” in
Chinese), a plant used in traditional Chinese medicine, and from other plants. It has been reported
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that when the concentration is at 30-45 µg/mL could exhibit an antibacterial effect and inhibit biofilm
formation of Staphylococcus epidermidis. Whether the biofilm formation inhibition of berberine observed
in Gram-positive bacteria is connected with the QS regulation is not confirmed [90]. However,
recent studies have shown that berberine inhibits the QS in Gram-negative bacteria including
antimicrobial-resistant E. coli strains, P. aeruginosa PA01, C. violaceum and Salmonella enterica [91,92].
Sun et al. investigated the QS inhibition activity of berberine in antimicrobial-resistant (AMR) E. coli
strains and found that berberine inhibited biofilm formation and downregulated QS-related genes
luxS, pfS, hflX, ftsQ, and ftsE of AMR E. coli strains at 1/2 (640 µg/mL) or 1/4 (320 µg/mL) minimal
inhibitory concentration (MIC) [90]. Thus the tested berberine concentrations of berberine were tested
by Sun et al. were ≥ 9.5 times higher than ours (cf. ≥ 160 µg/mL and 16.8 µg/mL in Sun et al.’s and our
study, respectively). Moreover, the AMR E. coli QS system is a LuxS/AI-mediated system, unrelated to
the LuxR-based circuitry present in our biosensor. Under our setting, we found no QS inhibition at
a berberine concentration of 50µM (16.8 µg/mL). The lower concentration tested in our assays may
explain the observed lack of QS inhibition activity. We decided to limit berberine concentration to
50 µM due to solubility problems at higher concentrations. Further efforts should be focused on testing
the QS inhibition potential of berberine and other related compounds at concentrations comparable to
those of Sun et al.’s and exploring whether the strong effect observed on LuxS-based QS systems can
be extrapolated to LuxR-regulated circuitries.
4. Materials and Methods
4.1. Library of Tested Chemical Compounds
Compounds were selected according to their chemical structure and were divided into five groups.
They were in all cases of high purity (≥90%) and were either commercially available or synthesised.
They were shipped in glass vials as powders or in liquid form and were dissolved in water or organic
solution (ethanol or methanol) before use. The details for each compound are given in Table 2.
Each is assigned a reference number used throughout this manuscript. 3-Oxohexanoyl-homoserine
lactone (3OC6HSL) and all other chemicals were of analytical grade and, unless otherwise stated, were
purchased from Merck KGaA (Darmstadt, Germany).
Table 2. List of screened compounds.
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Table 2. Cont.
Number Compounds Group 1 Solvent/Method Supplier
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1 The Group column refers to the classification based on chemical structural features (Figure 1), as explained in the
text; 2 Synthesised by Prof. Susane Fetzner according to the method of Eiden et al. [93]. HPLC and UV absorption
analysis indicated a purity of over 90%; 3 Synthesised by Prof. Susane Fetzner according to the method of Evans and
Eastwood [94]. HPLC and UV absorption analysis indicated a purity of over 90%; 4 Synthesised by Prof. Susane
Fetzner according to the method of Cornforth and James [95]. HPLC and UV absorption analysis indicated a purity
of over 90%.
4.2. Bacterial Strains
The QQ activity of the 23 selected compounds was determined using the E. coli Top 10 strains
listed below. The BioBrick standard biological sequence BBa_T9002, ligated into vector psb1a3
(http://partsregistry.org/Part:BBa_T9002), was a gift from Prof. Anderson (UC Berkeley, CA, USA).
The sequence BBa_T9002 was introduced by chemical transformation into E. coli Top 10 (Invitrogen,
Life Technologies Co., Leicestershire, UK) and single-colony cultures from the transformed strain were
stored as 30% glycerol stocks at −80 ◦C as described in Section 2.3 below. The sequence BBa_T9002
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comprised the transcription factor (LuxR), which is constitutively expressed, but it is active only in the
presence of the exogenous autoinducer signalling molecule 3OC6HSL. At an adequate concentration,
two molecules of 3OC6HSL bind to two molecules of LuxR and activate the expression of GFP (output),
under the control of the lux pR promoter from Vibrio fischeri. The fluorescence biosensor was calibrated
for different 3OC6HSL concentrations, as described in our previous studies [4]. An E. coli strain Top10
(Invitrogen, Life Technologies Co., U.K.) was transformed with plasmid pBCA9445-jtk2828, carrying
a superfolder version of the gfp gene (sfgfp), which was kindly donated by Prof. Anderson Lab (UC
Berkeley, Berkeley, CA, USA). The transformed strain expresses sfGFP constitutively and was used as
control culture to test possible fluorescence quenching artefacts of genipin and PYO that could account
for the effects observed in the fluorescence E. coli Top10 pSB1A3-BBaT9002 biosensor (Supporting
Information).
4.3. Growth Media and Glycerol Stocks Preparation
Bacterial strains were cultivated using on Luria-Bertani (LB) and M9 minimal medium purchased
from BD GmbH (Heidelberg, Germany). We inoculated 10 mL of LB broth supplemented with
200 µg/mL ampicillin with a single colony from a freshly streaked plate of Top10 containing BBa_T9002
and incubated the culture for 18 h at 37 ◦C, shaking at 100 rpm. Glycerol stocks were prepared as
described in our previous studies [38]. Briefly, a 500 µL aliquots of overnight bacterial culture were
mixed with 500 µL 30% sterile glycerol in 1.5 mL plastic vials and stored at −80 ◦C. Prior to each
experiment, an aliquot of a glycerol stock from the single culture was diluted 1:1000 into 20 mL
M9 minimal medium supplemented with 0.2% casamino acids, 1 mM thiamine hydrochloride and
200 µg/mL ampicillin (AppliChem GmbH, city, Germany). The culture was maintained under the
same conditions until the OD600 reached ~0.15 (~5 h).
4.4. E. coli Top10 Fluorescent Biosensor Assay
Each tested compound was dissolved in MilliQ water or 100% organic solution (ethanol or
methanol) according to their solubility at a high concentration of 200 mM, then diluted with MilliQ
water to produce samples at six concentrations: 2 × 10−2, 1 × 10−2, 1 × 10−3, 1 × 10−4, 1 × 10−7 and
1 × 10−8 M; however, some compounds can only be prepared at a maximal concentration of 50 µM
given by their water solubility. The 3OC6HSL was dissolved in acetonitrile to a stock concentration of
100 mM and stored at –20 ◦C kept in a sealed glass vial. Prior to each experiment, serial dilutions from
the AHL stock solution were prepared in water to produce solutions with a concentration ranging
from 100 mM to 10 nM. We then mixed 10 µL 3OC6HSL solution with 10 µL of the diluted compounds
at different concentrations in the wells of a flat-bottomed 96-well plate (cat. # M3061, Greiner Bio-One,
city, state abbrev if USA, country) and each well was then filled with 180 µL aliquots of the bacterial
culture to test for QS inhibition activity. The final inhibitor concentrations, therefore, ranged from
1 × 10−3 M to 5 × 10−10 M. Several controls were also set up. Blank 1 contained 180 µL of M9 medium
and 20 µL of MilliQ water to measure the absorbance background. Blank 2 wells contained 180 µL
of bacterial culture and 20 µL of MilliQ water to measure the absorbance background-corrected for
the cells. Finally, positive control wells contained 10 µL of water plus 10 µL 3OC6HSL solution and
180 µL of the bacterial culture to measure the fluorescence background. The plates were incubated in
a Safire Tecan-F129013 Microplate Reader (Tecan, Crailsheim, Germany) at 37 ◦C and fluorescence
measurements were taken automatically using a repeating procedure (λex = 480 nm and λem = 510 nm,
40 µs, 10 flashes, gain 100, top fluorescence), absorbance measurements (OD600) (λ = 600 nm absorbance
filter, 10 flashes) and shaking (5 s, orbital shaking, high speed). The interval between measurements
was 6 min. For each experiment, the fluorescence intensity (FI) and OD600 data were corrected by
subtracting the values of absorbance and fluorescence backgrounds and expressed as the average for
each treatment. Data were presented as FI/OD600 versus incubation time. All measurements were
taken in triplicate.
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4.5. Protein Structure File, Ligand Database
The X-ray crystal structure of Agrobacterium tumefaciens TraR was downloaded from the Protein
Data Bank (PDB ID 1L3L) and used for computer docking. All the water molecules were removed
except one molecule in the binding pocket, which plays an important role in interaction and forms the
hydrogen bond with the autoinducer OOHL of TraR protein. To define the grid box of TraR protein,
OOHL was used as a ligand to select spheres and also followed with the Information from the previous
study [18]. The 2D structures of six compounds (OOHL, MOQ, HOQ, MHOQ, PCA and PQS) were
drawn manually using Marvin sketch v6.1.3 (ChemAxon Ltd., Budapest, Hungary) and saved as MDL
mol files. The mol files were merged into a single mol file and likewise converted to 3D structures
using Discovery Studio 3.5 client software. PyMol was used for visualisation and molecular modelling.
4.6. Molecular Docking Studies
For the generation of GRID-MIFs (molecular interaction fields) at the TarR binding site where a
given chemical group can interact favourably, Autogrid program inbuilt in AutoDockTools 1.5.6. was
used. For MIF generation, mainly three probed were applied i.e., DRY probe representing hydrophobic
interaction, HA probe to representing H bond acceptor groups, and HD probe to representing H
bond donor groups. Docking guided by the grid map was performed using Autodock tool. Fifty
conformations were generated for each docked substrate. Binding scores between the ligand and
protein was evaluated using the autodock utility autoscorer considering the hydrogen bond forces,
electrostatic forces, van der Waals forces, solvation energy and entropy.
4.7. Statistical Analysis
All the experiments were performed in triplicates to validate reproducibility and the P values
were calculated statistically by Student’s t-test. Values were expressed as mean ±SD. A comparison
analysis was performed between tests and control.
5. Conclusions
In this study, we have screened the QS inhibition activity of a library of 23 structurally different
compounds against an E. coli Top10 pSB1A3-BBaT9002 reporter of AHL-regulated QS. This library
included a selection of natural and synthetic compounds that occur naturally in plants and in bacteria
species such as P. aeruginosa. We were able to establish cues of structure-function relationships for
compounds with QS inhibitory activity (e.g., trans-cinnamaldehyde, vanillin, caffeine, PQS, PCA).
We showed, for the first time, that genipin and MOQ have QS inhibition activity. We also conducted
molecular simulations using GRID-MIFs on a selection of compounds (e.g., MOQ, HOQ, MHOQ). Our
results aid in the future rational design of novel QS inhibition compounds. For example, the introduction
of a 3-methyl group in MOQ may increase the binding affinity substantially to the TraR receptor and
hence the QS inhibition activity. This hypothesis could be validated experimentally in future studies.
The results of this study may pave the way to future works aimed to fully realise the potential of QS
inhibition as an alternative strategy to overcome antimicrobial resistance and biofilms in clinical and
other settings.
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